Who Paid My Doc
Lisa Flores
Neuromusculoskeletal Medicine, Sports Medicine Tamuning, GU Medical Doctor
NPI 1124104195 CMS profile 1135630
Guam Seventh-Day Adventist Clinic, 388 Ypao Rd., Tamuning, GU 96913
General payments
$24
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Lisa Flores of Tamuning, GU is reported in the CMS Open Payments database as having received $24 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 14th percentile of Neuromusculoskeletal Medicine, Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $24 | 1 |
Beside peers
- Lisa Flores
- Neuromusculoskeletal Medicine, Sports Medicine median
- Middle half of Neuromusculoskeletal Medicine, Sports Medicine
- National median
In program year 2025, general payments to Lisa Flores were reported at $0. Among 69 Neuromusculoskeletal Medicine, Sports Medicine profiles paid that year, the median was $125 and the middle half received between $37 and $473.
Show as a table
| Year | Lisa Flores | Neuromusculoskeletal Medicine, Sports Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $152 | $43–$474 | $163 |
| 2020 | $0 | $113 | $31–$725 | $114 |
| 2021 | $0 | $167 | $50–$469 | $132 |
| 2022 | $0 | $132 | $46–$572 | $149 |
| 2023 | $0 | $109 | $39–$366 | $160 |
| 2024 | $24 | $115 | $37–$321 | $164 |
| 2025 | $0 | $125 | $37–$473 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 36 drugsPart D claims
1,429
Drug cost
$43,794
Branded share of claims
15.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | Brand | 23 | $14,185 | |
| Spiriva Handihaler Tiotropium Bromide | Brand | 15 | $7,828 | |
| Arexvy Rsvpref3 Antigen/As01e/Pf | Brand | 11 | $3,161 | |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | Brand | 13 | $1,883 | |
| Atorvastatin Calcium | Generic | 189 | $1,806 | |
| Amlodipine Besylate | Generic | 187 | $1,680 | |
| Rosuvastatin Calcium | Generic | 88 | $1,113 | |
| Losartan Potassium | Generic | 116 | $1,111 | |
| Levothyroxine Sodium | Generic | 65 | $947 | |
| Lantus Insulin Glargine,hum.Rec.Anlog | Brand | 13 | $878 |
The 10 drugs with the highest cost, of 36 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 85 billing codesPaid by Medicare
$130,013
Medicare patients
234
Services billed
3,063
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Diabetes | 46% | |
| Arthritis | 22% | |
| Osteoporosis | 21% | |
| Chronic kidney disease | 18% | |
| Ischemic heart disease | 14% | |
| Heart failure | 13% | |
| COPD | 11% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Sarscv2 vac 30mcg trs-suc im 91320 | Office | 53 | 58 | $7,962 |
| Vaccine for influenza for injection into muscle 90662 | Office | 100 | 100 | $7,855 |
| Pcv20 vaccine im 90677 | Office | 14 | 14 | $4,052 |
| Influenza vaccine, trivalent, 0.5 ml dosage 90658 | Office | 14 | 14 | $300 |
| Vaccine for influenza for administration into muscle, 0.5 ml dosage 90688 | Office | 11 | 11 | $225 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Neuromusculoskeletal Medicine, Sports Medicine in Guam
Practitioners in the same specialty and state, ranked by reported value.
All Neuromusculoskeletal Medicine, Sports Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Guam
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.